Ping Yan

机构：Weifang Medical University, Xinjiang Medical University, Xinjiang Uygur Autonomous Region Disease Prevention and Control Center · ORCID：0000-0003-4237-9875

发表论文 76 篇 · 总被引 3800 次 · h-index 27

代表论文

• Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial (2021 · ˜The œLancet. Gastroenterology & hepatology · 被引 260)
• Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial (2021 · Nature Medicine · 被引 178)
• Machine learning for early discrimination between transient and persistent acute kidney injury in critically ill patients with sepsis (2021 · Scientific Reports · 被引 64)
• Machine Learning–Based Prediction of Acute Kidney Injury Following Pediatric Cardiac Surgery: Model Development and Validation Study (2023 · Journal of Medical Internet Research · 被引 60)
• Development and Validation of Machine Learning Models for Real-Time Mortality Prediction in Critically Ill Patients With Sepsis-Associated Acute Kidney Injury (2022 · Frontiers in Medicine · 被引 43)
• Outcome prediction for acute kidney injury among hospitalized children via eXtreme Gradient Boosting algorithm (2022 · Scientific Reports · 被引 35)